From: Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
Variable | Categorization | Tumor progression | ||
---|---|---|---|---|
na | events | pb | ||
Pathologic data: | ||||
Tumor stage (WHO 1973c) | ||||
pTa | 85 | 10 | 0.412 | |
pT1 | 68 | 12 | ||
Histologic grade (WHO 1973c) | ||||
G1 | 43 | 3 | 0.093 | |
G2 | 82 | 12 | ||
G3 | 28 | 7 | ||
Histologic grade (WHO 2004d) | ||||
Low grade | 95 | 10 | 0.092 | |
High grade | 58 | 12 | ||
Adjacent carcinoma in situ | ||||
No | 141 | 20 | 0.570 | |
Yes | 12 | 2 | ||
Multifocality | ||||
Unifocal tumor | 111 | 15 | 0.486 | |
Multifocal tumor | 42 | 7 | ||
Growth pattern | ||||
Papillary | 146 | 17 | <0.0001 | |
Solid | 7 | 5 | ||
Immunohistochemistry: | ||||
HDAC-1 | ||||
Low expression | 92 | 9 | 0.085 | |
High expression | 61 | 13 | ||
HDAC-2 | ||||
Low expression | 88 | 12 | 0.628 | |
High expression | 65 | 10 | ||
HDAC-3 | ||||
Low expression | 65 | 8 | 0.754 | |
High expression | 88 | 14 | ||
Ki-67 IHC | ||||
Low expression | 101 | 9 | 0.004 | |
High expression | 52 | 13 |